Search
Search results
59 results found
Contact Us
Lenvatinib Targets PDGFR-β Pericytes and Inhibits Synergy With Thyroid Carcinoma Cells: Novel Translational Insights.
Iesato, Asumi, Stephanie Li, Giovanni Roti, Michele R Hacker, Andrew H Fischer, and Carmelo Nucera. 2021. “Lenvatinib Targets PDGFR-β Pericytes and Inhibits Synergy With Thyroid Carcinoma Cells: Novel Translational Insights.”. The Journal of Clinical Endocrinology and Metabolism 106 (12): 3569-90.
Clonal Reconstruction of Thyroid Cancer: An Essential Strategy for Preventing Resistance to Ultra-Precision Therapy.
McGonagle, Elizabeth R, and Carmelo Nucera. 2019. “Clonal Reconstruction of Thyroid Cancer: An Essential Strategy for Preventing Resistance to Ultra-Precision Therapy.”. Frontiers in Endocrinology 10: 468.
The BRAFV600E mutation: what is it really orchestrating in thyroid cancer?
Nucera, Carmelo, Jack Lawler, Richard Hodin, and Sareh Parangi. 2010. “The BRAFV600E Mutation: What Is It Really Orchestrating in Thyroid Cancer?”. Oncotarget 1 (8): 751-56.
FOXA1 is a potential oncogene in anaplastic thyroid carcinoma.
Nucera, Carmelo, Jerome Eeckhoute, Stephen Finn, Jason S Carroll, Azra H Ligon, Carmen Priolo, Guido Fadda, et al. 2009. “FOXA1 Is a Potential Oncogene in Anaplastic Thyroid Carcinoma.”. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 15 (11): 3680-9.
Effects of thyroidectomy alone or followed by radioiodine ablation of thyroid remnants on the outcome of graves' ophthalmopathy.
Moleti, Mariacarla, Filiberto Mattina, Ignazio Salamone, Maria Antonia Violi, Carmelo Nucera, Sergio Baldari, Maria Grazia Lo Schiavo, Concetto Regalbuto, Francesco Trimarchi, and Francesco Vermiglio. 2003. “Effects of Thyroidectomy Alone or Followed by Radioiodine Ablation of Thyroid Remnants on the Outcome of Graves’ Ophthalmopathy.”. Thyroid : Official Journal of the American Thyroid Association 13 (7): 653-8.
Anna Helman
Dr. Nucera awarded with the highly competitive DOD PRCRP Impact award Grant
Link to Article